Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

1,197 evidence items · page 10 / 48

78.5 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 78.5% showed a 2-fold increase in anti-CSP IgG antibody titres post-2021 as measured by GSK ELISA.

Burkina Faso · Malipaludismeobserved post-2021HAL · Unilimdocument of 105 observations

92.9 %The level of Plasmodium falciparum clinical response to Artesunate-Amodiaquine was 92.9% (156/168) of Adequate Clinical and Parasitological Response before molecular correction.

Malipaludismepublished 2021The Journal of parasitologyeurope_pmcdocument of 8 observations

6,981,000 décèsPrès de 6 981 000 décès liés au COVID-19 avaient eu lieu dans le monde d'ici la fin de 2019.

MaliCOVID-19observed fin de 2019HAL · Unilimdocument of 36 observations

3 timesDans la population sénégalaise, la proportion de patients présentant une TRJV élevée est trois fois plus forte que dans la population malienne.

Mali · SénégaldrépanocytoseHAL · Unilimdocument of 202 observations

12.4 %Malaria infection prevalence was 12.4% in 2014 among children in the health district of Koutiala, Mali.

Malipaludismeobserved 2014published 2020International journal of environmental research and public healtheurope_pmcdocument of 7 observationsDOI 10.3390/ijerph17186639

0.9 %For the final 16-month follow-up period, vaccine efficacy was 0.9% against all malaria episodes.

Malipaludismepublished 2013PloS oneeurope_pmcdocument of 2 observations

1 %The distribution of G6PD*A- deficiency was 1%, 7%, and 9.8% respectively for homozygous, hemizygous, and heterozygous genotypes.

Maliglucose-6-phosphate dehydrogenase deficiencypublished 2010Malaria journaleurope_pmcdocument of 6 observationsDOI 10.1186/1475-2875-9-332

65.2 %Malaria prevalence from all Plasmodium species was 65.20% in passive screening.

Malipaludismepublished 2023Tropical medicine and infectious diseaseeurope_pmcdocument of 16 observations

25 childrenPlasmodium vivax was detected in 25 Duffy-negative children in Bandiagara, Mali.

Malipaludismepublished 2017The American journal of tropical medicine and hygieneeurope_pmcdocument of 4 observations

50 %Half of the true mis-identified sickle cell disease cases were related to the β-plus-thalassaemia allele.

Malidrépanocytose · β-plus-thalassaemiaHAL · Unilimdocument of 103 observations

90 %Plasmodium falciparum malaria cases in Africa represent over 90% of the global burden.

Malipaludismepublished 2022Frontiers in geneticseurope_pmcdocument of 5 observations

97.3 %P. falciparum was the most predominant species, accounting for 97.3% of Plasmodium-positive samples.

Malipaludismepublished 2023Performance of Rapid Diagnostic Tests for Malaria Diagnosis in Malieurope_pmcdocument of 3 observationsDOI 10.20944/preprints202311.1579.v1

0.26 per_hourThe parasite clearance rate constant was 0.26 per hour for dihydroartemisinin-piperaquine.

Malipaludismepublished 2018Malaria journaleurope_pmcdocument of 9 observations

94.9 %Crude ACPRs were 94.9% for SP + AS, 98.6% for SP + AQ, and 93.5% for SP alone in the treatment of uncomplicated P. falciparum malaria in Mali.

Malipaludismepublished 2015Malaria journaleurope_pmcdocument of 7 observations

36 health_districtsAn additional 36 health districts in Mali will receive the malaria vaccine in 2026.

Malipaludismeobserved 2026HAL · Unilimdocument of 95 observations

88.2 %In a phase 2 trial in Mali, the efficacy of 40 mg of CIS43LS per kilogram as compared with placebo against Plasmodium falciparum infection was 88.2% at 6 months.

Malipaludismepublished 2022The New England journal of medicineeurope_pmcdocument of 5 observations

2.02 IRRTraditionally Wealth Households (TWH) had an incidence rate ratio of 2.02 for SARS-CoV-2 seropositivity compared to Low-Wealth Households (LWH).

MaliCOVID-19HAL · Unilimdocument of 88 observations

0.48 SIRDeployment of mobile health teams led to a standardized incidence ratio of 0.48 for malaria morbidity in Kidal, Mali.

MalipaludismeHAL · Unilimdocument of 80 observations

25 %Pericopsis laxiflora était utilisé contre les douleurs musculaires avec une fréquence de citation de 25 %.

Malidouleurs musculairesHAL · Unilimdocument of 20 observations

MSP-1(42) antibody levels were significantly higher in malaria vaccine recipients after the second immunization relative to baseline and to the control group.

Malipaludismepublished 2006PLoS clinical trialseurope_pmcdocument of 2 observations

12.2 per_1000_person_yearsThe lowest malaria incidence was 12.2 cases per 1,000 person-years in the health district of Al-Ourche (Taoudenni region in the north) in the year 2017–2018.

Malipaludismeobserved 2017–2018HAL · Unilimdocument of 111 observations

1,014 casesThe malaria outbreak peaked in week 39 with 1,014 cases in the Kidal region.

MalipaludismeHAL · Unilimdocument of 80 observations

25 %Seulement un quart des participants anémiques présentaient des symptômes cliniques.

MalianémieHAL · Unilimdocument of 214 observations

3 %Plasmodium malariae infections showed a high frequency of 3%–15% with a significant reduction in ex vivo susceptibility to chloroquine, lumefantrine, and artemether.

MaliPlasmodium malariae infectionspublished 2021The Journal of antimicrobial chemotherapyeurope_pmcdocument of 4 observations

1.5 %P. malariae prevalence was 1.50% in passive screening.

Malipaludismepublished 2023Tropical medicine and infectious diseaseeurope_pmcdocument of 16 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.